Sökning: onr:"swepub:oai:DiVA.org:liu-167734" > Risk factors for pe...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04639naa a2200529 4500 | |
001 | oai:DiVA.org:liu-167734 | |
003 | SwePub | |
008 | 200721s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1677342 URI |
024 | 7 | a https://doi.org/10.1007/s00380-020-01653-62 DOI |
040 | a (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Droppa, Michalu Univ Hosp Tubingen, Germany4 aut |
245 | 1 0 | a Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis |
264 | c 2020-06-26 | |
264 | 1 | b Springer,c 2020 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies|Edwards Lifesciences (Nyon, Switzerland) | |
520 | a Permanent pacemaker implantation (PPI) is a widely recognized complication associated with TAVI (incidence up to 20%). Smaller registries have identified several variables associated with PPI. The objective was to validate patient- and transcatheter aortic valve implantation (TAVI)-related procedural variables associated with PPI. We performed a retrospective analysis of patients from six European centers undergoing TAVI with the Edwards SAPIEN 3 prosthesis. Baseline variables and pre-procedural ECG characteristics and CT-scans were taken into account. Data for 1745 patients were collected; 191 (10.9%) required PPI after TAVI. The baseline variables pulmonary hypertension (OR 1.64; 95% CI 1.01-2.59), QRS duration > 117 ms (OR 2.58; 95% CI 1.73-3.84), right bundle branch block (RBBB; OR 5.14; 95% CI 3.39-7.72), left anterior hemi block (OR 1.92; 95% CI 1.19-3.02) and first-degree atrioventricular block (AVB, OR 1.63; 95%CI 1.05-2.46) were significantly associated with PPI. RBBB (OR 8.11; 95% CI 3.19-21.86) and first-degree AVB (OR 2.39; 95% CI 1.18-4.66) remained significantly associated in a multivariate analysis. Procedure-related variables included access site (TF; OR 1.97; 95% CI 1.07-4.05), implanted valve size (29 mm; OR 1.88; 95% CI 1.35-2.59), mean TAVI valve implantation depth below the annulus > 30% (OR 3.75; 95% CI 2.01-6.98). Patients receiving PPI had longer ICU stays and later discharges. Acute kidney injury stage 2/3 was more common in patients with PPI until discharge (15.2 vs. 3.1%;p = 0.007), but was not statistically significant thereafter. Further differences in outcomes at 30 days did not reach significance. The data will aid pre- and post-procedural patient management and prevent adverse long-term outcomes. Clinical Trial: NCT03497611. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kirurgi0 (SwePub)302122 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Surgery0 (SwePub)302122 hsv//eng |
653 | a Aortic stenosis; Transcatheter aortic valve implantation; Pacemaker | |
700 | 1 | a Rudolph, Tanja K.u Cologne Univ, Germany; Heart and Diabet Ctr NRW, Germany4 aut |
700 | 1 | a Baan, Janu Univ Amsterdam, Netherlands4 aut |
700 | 1 | a Nielsen, Niels Erik,d 1956-u Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US4 aut0 (Swepub:liu)nieni36 |
700 | 1 | a Baumgartner, Helmutu Univ Hosp Muenster, Germany4 aut |
700 | 1 | a Vendrik, Jeroenu Univ Amsterdam, Netherlands4 aut |
700 | 1 | a Froehlich, Marenu Inst Pharmacol and Prevent Med, Germany4 aut |
700 | 1 | a Borst, Oliveru Univ Hosp Tubingen, Germany4 aut |
700 | 1 | a Woehrle, Jochenu Univ Ulm, Germany4 aut |
700 | 1 | a Gawaz, Meinradu Univ Hosp Tubingen, Germany4 aut |
700 | 1 | a Potratz, Paulu Univ Hosp Tubingen, Germany4 aut |
700 | 1 | a Hack, Luis P.u Univ Hosp Tubingen, Germany4 aut |
700 | 1 | a Mauri, Victoru Cologne Univ, Germany4 aut |
700 | 1 | a Baranowski, Jaceku Region Östergötland, Kardiologiska kliniken US4 aut0 (Swepub:liu)n/a |
700 | 1 | a Bramlage, Peteru Inst Pharmacol and Prevent Med, Germany4 aut |
700 | 1 | a Kurucova, Janau Edwards Lifesci, Czech Republic4 aut |
700 | 1 | a Thoenes, Martinu Edwards Lifesci, Switzerland4 aut |
700 | 1 | a Rottbauer, Wolfgangu Univ Ulm, Germany4 aut |
700 | 1 | a Geisler, Tobiasu Univ Hosp Tubingen, Germany4 aut |
710 | 2 | a Univ Hosp Tubingen, Germanyb Cologne Univ, Germany; Heart and Diabet Ctr NRW, Germany4 org |
773 | 0 | t Heart and Vesselsd : Springerg 35, s. 1735-1745q 35<1735-1745x 0910-8327x 1615-2573 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-167734 |
856 | 4 8 | u https://doi.org/10.1007/s00380-020-01653-6 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy